Amiloidosi AL
A phase 2 study of Belantamab Mafodotin in patients with relapsed or refractory AL amyloidosis
Di prossima attivazione:
Amiloidosi AL
A phase 2 study of Belantamab Mafodotin in patients with relapsed or refractory AL amyloidosis
Di prossima attivazione:
Amiloidosi ATTR